Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer

被引：0
|
作者：
Ulysses Ribeiro
机构：
[1] Universidade de São Paulo (ICESP- HCFMUSP),Department of Gastroenterology, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas, Faculdade de Medicina
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1945 / 1947
页数：2
相关论文
共 50 条
  • [41] Diffusion-weighted magnetic resonance imaging for predicting pathologic response to neoadjuvant chemoradiotherapy in esophageal squamous cell cancer.
    Hao, Daxuan
    Yang, Yuanyuan
    Li, Xue
    Wu, Xiaoyuan
    Chen, Yongshun
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Predicting Pathologic Complete Response after Neoadjuvant Chemotherapy
    Imbriaco, Massimo
    Ponsiglione, Andrea
    RADIOLOGY, 2021, 299 (02) : 301 - 302
  • [44] Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer
    Zhang, Z.
    Zhang, H.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (04) : 1 - 7
  • [45] Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?
    Puja G. Khaitan
    Tyler Holliday
    Austin Carroll
    Wayne L. Hofstetter
    Erin M. Bayley
    Nicolas Zhou
    Sameer Desale
    Thomas J. Watson
    Journal of Gastrointestinal Surgery, 2022, 26 : 1345 - 1351
  • [46] Tumor-stroma ratio for predicting pathologic response after chemoradiotherapy in esophageal cancer
    Lips, I.
    Van Pelt, G. W.
    Peters, F. P.
    Krol, J. A.
    Van Klaveren, D.
    Boonstra, J. J.
    De Steur, W. O.
    Sarasqueta, A. Farina
    Mesker, W. E.
    Slingerland, M.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S331 - S332
  • [47] Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?
    Khaitan, Puja G.
    Holliday, Tyler
    Carroll, Austin
    Hofstetter, Wayne L.
    Bayley, Erin M.
    Zhou, Nicolas
    Desale, Sameer
    Watson, Thomas J.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (07) : 1345 - 1351
  • [48] Predictors and risk factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Tan, Yinuo
    Fu, Dongliang
    Jiang, Kai
    Kong, Xiangxing
    Yuan, Ying
    Ding, Kefeng
    ANNALS OF ONCOLOGY, 2018, 29
  • [49] Gender, Racial and Ethnic Differences in Pathologic Response Following Neoadjuvant Chemotherapy for Bladder Cancer Patients
    Paster, Irasema Concepcion
    Zeng, Jiping
    Recio-Boiles, Alejandro
    Chipollini, Juan
    UROLOGY, 2023, 178 : 105 - 113
  • [50] GENDER, RACIAL AND ETHNIC DIFFERENCES IN PATHOLOGIC RESPONSE FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR BLADDER CANCER PATIENTS
    Paster, Irasema
    Zeng, Jiping
    Recio-Boiles, Alejandro
    Chipollini, Juan
    JOURNAL OF UROLOGY, 2023, 209 : E632 - E632
12345